Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Hold
3,215
﹤0.01% 326
2026
Q1
$269K Hold
3,215
﹤0.01% 311
2025
Q4
$216K Hold
3,215
﹤0.01% 318
2025
Q3
$217K Hold
3,215
﹤0.01% 319
2025
Q2
$240K Hold
3,215
﹤0.01% 316
2025
Q1
$202K Buy
+3,215
New +$199K ﹤0.01% 331
2019
Q3
Sell
-7,626
Closed -$226K 354
2019
Q2
$226K Buy
+7,626
New +$205K ﹤0.01% 343

Other funds holding CTVA

Bahl & Gaynor's CTVA Position: Q2 2026 in Review

Bahl & Gaynor held its Corteva (CTVA) position steady in Q2 2026 at 3,215 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Bahl & Gaynor first reported a position in CTVA in Q2 2019 and has held it in 7 quarters since. 1,489 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Bahl & Gaynor held 3,215 shares of Corteva worth $272K as of Q2 2026.
  • Bahl & Gaynor left its Corteva share count unchanged in Q2 2026.
  • Corteva made up ﹤0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #326 holding.
  • Bahl & Gaynor first reported a position in Corteva in Q2 2019 and has held it in 7 quarters since.
  • 1,489 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.